KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Optimizing the use of vilobelimab for the treatment of COVID-19.Expert Opin Biol TherPMID 37421632无 PMCID20230.98未发现恶性肿瘤人群证据。待处理
Fibrin Sealant TISSEEL Lyo as a haemostatic agent in vascular surgery: Results of randomized, controlled, patient-blinded, multicentre clinical study in the Russian population.Sci ProgPMID 37427979PMC1035863420230.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.PLoS OnePMID 37582114PMC1042695320230.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial.Front ImmunolPMID 37799724PMC1054882420230.98未发现恶性肿瘤人群证据。待处理
Durability of the deltamethrin-treated polypropylene long-lasting net LifeNet® in a pyrethroid resistance area in south western Benin: A phase III trial.PLoS OnePMID 37729177PMC1051106720230.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial.Pediatr DermatolPMID 37455588无 PMCID20230.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Type-I-error rate inflation in mixed models for repeated measures caused by ambiguous or incomplete model specifications.Pharm StatPMID 37519010无 PMCID20230.98未发现恶性肿瘤人群证据。待处理
Diagnostic accuracy and predictive validity of combined use of Fototest and Mini-Cog in cognitive impairment.Neurologia (Engl Ed)PMID 37858894无 PMCID20230.98未发现恶性肿瘤人群证据。待处理
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.HeadachePMID 37955395无 PMCID20230.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study.Hum Vaccin ImmunotherPMID 33957854PMC89201612022-Dec-310.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.Hum Vaccin ImmunotherPMID 34473607PMC89202142022-Dec-310.98未发现恶性肿瘤人群证据。待处理
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).Hum Vaccin ImmunotherPMID 34726574PMC89201442022-Dec-310.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial.Hum Vaccin ImmunotherPMID 35192784PMC89424472022-Dec-310.98未发现恶性肿瘤人群证据。待处理
A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.BMC CancerPMID 36585629PMC98052762022-Dec-300.90The record is a Phase III randomized trial protocol for brain metastases with a time-to-event endpoint, but it is ineligible because it is a protocol without results and does not involve a drug intervention.待处理
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial.Int J Mol SciPMID 36613994PMC98206142022-Dec-290.98未发现恶性肿瘤人群证据。待处理
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.BMC MedPMID 36575513PMC97957512022-Dec-270.85The study is a Phase III randomized trial of a drug intervention in oncology (breast cancer) and reports original results, but the primary and only reported efficacy endpoint is pathological complete response rate, which is not a time-to-event endpoint. No time-to-event endpoint (OS, PFS, DFS, etc.) or time-to-event analysis (Kaplan-Meier curve, hazard ratio) is described or presented.待处理
Randomized, double-blind, noninferiority study of diclofenac diethylamine 2.32% gel applied twice daily versus diclofenac diethylamine 1.16% gel applied four times daily in patients with acute ankle sprain.BMC Musculoskelet DisordPMID 36566202PMC97896402022-Dec-240.98未发现恶性肿瘤人群证据。待处理
GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.J Antimicrob ChemotherPMID 36308328无 PMCID2022-Dec-230.98未发现恶性肿瘤人群证据。待处理
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.J Antimicrob ChemotherPMID 36322466PMC102054742022-Dec-230.98未发现恶性肿瘤人群证据。待处理
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.N Engl J MedPMID 36546625无 PMCID2022-Dec-220.98未发现恶性肿瘤人群证据。待处理
Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.TrialsPMID 36539781PMC97689882022-Dec-210.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma.J Clin OncolPMID 35862871PMC99160402022-Dec-200.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial.J Clin OncolPMID 35930754无 PMCID2022-Dec-200.90The record describes a Phase III randomized trial comparing two radiation therapy techniques (partial vs. whole breast irradiation) for early breast cancer. While it is an oncology, human, randomized, Phase III trial with original results, it does not meet the core eligibility criteria. The intervention is non-drug (radiation only), and the primary endpoint is a morbidity/toxicity measure (breast induration), not a time-to-event efficacy endpoint (OS, PFS, DFS, etc.).待处理
Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study.Chin Med J (Engl)PMID 36580650PMC101062142022-Dec-200.98未发现恶性肿瘤人群证据。待处理
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.N Engl J MedPMID 36516090无 PMCID2022-Dec-150.98未发现恶性肿瘤人群证据。待处理
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.J Am Coll CardiolPMID 36328157无 PMCID2022-Dec-130.98未发现恶性肿瘤人群证据。待处理
Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).Br J SurgPMID 36369984无 PMCID2022-Dec-130.99The study meets criteria for a Phase III randomized oncology trial with a time-to-event primary endpoint (OS) and is an original result report. However, it is excluded because the intervention is surgical (bursectomy vs. omentectomy) and does not contain a drug-based treatment, which is a required criterion.待处理
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial.BMC CancerPMID 36514034PMC97461462022-Dec-130.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?BMC CancerPMID 36503429PMC97436232022-Dec-120.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.J Clin OncolPMID 35759733PMC97467792022-Dec-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.BloodPMID 35984904无 PMCID2022-Dec-080.85While the study is an oncology randomized phase III trial with a drug intervention, it does not explicitly report formal time-to-event efficacy endpoints (e.g., OS, PFS, DFS) with standard metrics (Kaplan-Meier, HR) in the abstract. The focus is on mechanistic analysis of relapse association, not on primary efficacy results, so is_eligible is set to false.待处理
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study.Jpn J Clin OncolPMID 36073950PMC97214572022-Dec-050.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Effectiveness of postoperative oral administration of cephalexin and metronidazole on surgical site infection among obese women undergoing cesarean section: a randomized, double-blind, placebo-controlled, parallel-group study-phase III.Antimicrob Resist Infect ControlPMID 36471429PMC97243552022-Dec-050.98未发现恶性肿瘤人群证据。待处理
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.LancetPMID 36356632无 PMCID2022-Dec-030.98未发现恶性肿瘤人群证据。待处理
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer.Mol Cancer TherPMID 36198026无 PMCID2022-Dec-020.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study.J Headache PainPMID 36460983PMC97166942022-Dec-020.98未发现恶性肿瘤人群证据。待处理
Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.J NeurosurgPMID 35364589无 PMCID2022-Dec-010.98未发现恶性肿瘤人群证据。待处理
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).J Clin OncolPMID 35658487PMC97467822022-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.Am J Respir Crit Care MedPMID 35816621PMC97468692022-Dec-010.98未发现恶性肿瘤人群证据。待处理
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.J Clin OncolPMID 35834777PMC104768412022-Dec-011.00命中用户提供的消化道肿瘤阳性参考集。待处理
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.J Clin OncolPMID 35947817PMC97467712022-Dec-011.00命中用户提供的消化道肿瘤阳性参考集。待处理
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial.JAMA CardiolPMID 36190011PMC95310912022-Dec-010.98未发现恶性肿瘤人群证据。待处理
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.Crit Care MedPMID 36226977PMC96683612022-Dec-010.98未发现恶性肿瘤人群证据。待处理
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.JAMA OncolPMID 36264568PMC95854612022-Dec-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.JAMA NeurolPMID 36315128PMC96234772022-Dec-010.98未发现恶性肿瘤人群证据。待处理
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.Crit CarePMID 36457059PMC97140152022-Dec-010.98未发现恶性肿瘤人群证据。待处理
Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw OpenPMID 36580332PMC98569672022-Dec-010.98未发现恶性肿瘤人群证据。待处理
The efficacy and tolerability of pollen extract in combination with hyaluronic acid and vitamins in the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome: a 26 weeks, randomized, controlled, single-blinded, phase III study.Minerva Urol NephrolPMID 33781014无 PMCID2022-Dec0.98未发现恶性肿瘤人群证据。待处理
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.Asia Pac J Clin OncolPMID 35357078无 PMCID2022-Dec0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study.Int Urogynecol JPMID 35389054PMC96663072022-Dec0.98未发现恶性肿瘤人群证据。待处理